Printer Friendly
The Free Library
14,632,880 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CN Biosciences Changes Name to EMD Biosciences With Continued Focus On Providing Customer-Centric Service and On-Demand Tools for Life Science Research.


Business Editors & Health/Medical Writers

BIOWIRE2K

SAN DIEGO--(BUSINESS WIRE)--Feb. 3, 2003

U.S. Businesses Renamed to Support Global

Brand Recognition for Merck KGaA This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article.

CN Biosciences, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced a name change to EMD EMD Electromechanical dissociation, see there  Biosciences, Inc. (www.emdbiosciences.com), with an enhanced focus on customer-centric service and continued dedication to providing on-demand tools for life science research. The name change was effective January 1, 2003.

EMD Biosciences is a part of Merck KGaA's global Life Science Products Division. The company operates as EMD Biosciences, Inc. in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  and Merck Biosciences outside North America. Globally, EMD Biosciences focuses on development, production, marketing, sales, and distribution of a broad array of products used worldwide in disease-related life science research at pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 as well as in academia. The company has four established product brands, Calbiochem(R), Novabiochem(R), Novagen(R) and Oncogene oncogene

Gene that can cause cancer. It is a sequence of DNA that has been altered or mutated from its original form, the proto-oncogene (see mutation). Proto-oncogenes promote the specialization and division of normal cells.
 Research Products(TM), which provide chemical and biological reagents needed for research areas such as signal transduction Signal transduction

The transmission of molecular signals from a cell's exterior to its interior. Molecular signals are transmitted between cells by the secretion of hormones and other chemical factors, which are then picked up by different cells.
, peptide synthesis In organic chemistry, peptide synthesis is the creation of peptides, which are organic compounds in which multiple amino acids bind via peptide bonds which are also known as amide bonds. , combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction
Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules.
, apoptosis, proteomics, and genetic analysis.

"We are proud to carry the EMD name and help support Merck KGaA's presence in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  by providing tools to advance the process of scientific discovery," stated Robert Mierendorf, Ph.D., Chief Technology Officer of EMD Biosciences, Inc. "Our company understands the importance of maintaining open communication with scientists in the field, our customers, and we continuously strive to remain at the forefront of the trends shaping the future of life science research," continued Dr. Mierendorf.

EMD Biosciences applies five key focus areas of excellence to each of its brands.
-- Application-Specific Expertise -- The company's scientists follow the latest research trends and quickly develop specific products to support the most promising research approaches.

-- Depth of Application-Specific Products -- EMD Biosciences strives to maintain the broadest catalog of products available in several research categories.

-- Products that Perform -- The company delivers high-quality, reliable research tools that perform as expected.

-- Products on Demand -- EMD Biosciences strives to have the products scientists and researchers need, always in stock and delivered on time.

-- Responsive Customer and Technical Support -- The company provides superior customer and technical support including extensive written documentation and dedicated, highly-trained staff available at brand centers and sales points.


For further information, please check the websites of Merck KGaA (www.merck.de), EMD Biosciences (www.emdbiosciences.com), Calbiochem(R) (www.calbiochem.com), Novabiochem(R) (www.novabiochem.com), Novagen(R) (www.novagen.com) and Oncogene Research Products(TM) (www.apoptosis.com).

About EMD Biosciences, Inc.

EMD Biosciences, Inc. is the new name for CN Biosciences (CNBI CNBI Communications Network Billing, Inc. ), an affiliate of Merck KGaA, Darmstadt, Germany since 1999. CNBI was founded in 1992 with two brands, Calbiochem(R) and Novabiochem(R), and subsequently acquired Oncogene Research Products(TM) and Novagen(R) brands in 1995 and 1997, respectively. Operations are based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
 (USA); Laufelfingen, Switzerland; Madison, Wisconsin (USA); Nottingham, UK; and Schwalbach, Germany.

The company is engaged in the development, production, marketing, sales and distribution of a broad array of products used worldwide in disease-related life science research at universities and pharmaceutical and biotechnology companies. EMD Biosciences is part of Merck KGaA's Life Science Products (LSP LSP - Label Switched Path ) division. The company operates as EMD Biosciences, Inc. in North America and Merck Biosciences outside North America. Globally, EMD Biosciences is dedicated to advancing life science research and discovery through delivering innovative, reliable products with unsurpassed customer and technical support.

EMD Biosciences and its brands enable Merck KGaA to further broaden its product outreach, offering researchers in life sciences a single on-demand source for a broad range of optimum-quality products, supported by superior customer service. For more information, please visit the company's Web site at www.emdbiosciences.com.

About Merck KGaA

With more than 34,000 employees in 55 countries, the Merck Group (www.merck.de) generated sales of EUR EUR

In currencies, this is the abbreviation for the Euro.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 7.5 billion in 2001. Founded in 1668 in Darmstadt, Germany, the company aims to be a world leader within its core businesses of pharmaceuticals and chemicals. The Merck Group strongly believes the key to its long-term business success is innovative products created by entrepreneurial and talented employees. Merck groups its operating activities under Merck KGaA, in which the Merck family holds 74% and the remaining 26% is publicly traded. The former United States subsidiary, Merck & Co., has been a completely independent company since 1917. Generally, Merck KGaA holds the exclusive rights to the Merck name worldwide except in North America, where name rights belong to its former U.S. subsidiary, Merck & Co, Inc.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUGE
Date:Feb 3, 2003
Words:751
Previous Article:Cubic Corp. Reports Fiscal 2003 First Quarter Sales up 20 Percent, Earnings up 17 Percent.
Next Article:MultiCell Technologies Signs License Agreement with Major Pharmaceutical Company.
Topics:



Related Articles
Biopharmaceutical Leader and V3 Global Cross International Borders for E-Commerce Success.
Nonlinear Dynamics and Amersham Biosciences Announce Further Collaboration by Signing Exclusive Software Deal For ImageQuant TL-TM-.
Norak Biosciences Purchases Second IN Cell Analyzer 3000 from Amersham Biosciences.
EMD Biosciences Inc. Forms Strategic Partnership with The Automation Partnership for Rapid Implementation of an Automated Protein Purification System.
EMD Releases the Inhibitor SourceBook, the First Comprehensive Guide to Inhibitors for Signal Transduction Research and Drug Discovery.
EMD Releases New Web-Based Signal Transduction Interactive Pathways.
EMD Biosciences, Inc. Enters into a Cooperative Agreement with the RZPD German Resource Center for Genome Research; EMD Biosciences Antibody Products...
EMD Biosciences, Inc. and MorphoSys' Antibodies by Design Offer First Recombinant Antibody; For Detection of Cyclophilin A, a Component of Protein...
R&D 100 Award-Winning Bacterial Culture System is Available from EMD Biosciences, Inc.; EMD Biosciences Attends 2004 R&D 100 Award Ceremony.
EMD Biosciences Releases Substructure Searchable Inhibitor Database Files.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles